SCHEMBL7230946

SCHEMBL7230946

COC(=O)CCc1ccc2oc(CC(NS(=O)(=O)NC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)cc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.38
CA14 Q9ULX7 3/20 0.38
CA2 P00918 1/20 0.36
CA1 P00915 1/20 0.35
CA7 P43166 1/20 0.35
PTPN1 P18031 3/20 0.35
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
AGTR1 P30556 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
FFAR1 O14842 3/20 0.33
PTPRB P23467 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6973854 0.93 CA12 (0.37) CA12CA14CA2CA1CA7
SCHEMBL7223443 0.84 ALDH1A1 (0.41) ALDH1A1MAPTNPSR1FFAR1HIF1A
SCHEMBL7230948 0.82 CA12 (0.37) CA12CA14CA2CA1CA7
SCHEMBL7224783 0.81 TDP1 (0.37) PTPN1ALDH1A1MAPTHPGDLMNA
SCHEMBL7228562 0.81 LMNA (0.37) CA12CA14CA2CA7PTPN1
SCHEMBL7231335 0.80 CASP1 (0.47) ALDH1A1HPGDLMNAHTTCTSB
SCHEMBL7231808 0.77 EPHX2 (0.36) ALDH1A1HPGDLMNANPSR1KDM4E
SCHEMBL6973856 0.75 CA12 (0.37) CA12CA14CA2CA1CA7
SCHEMBL6973099 0.75 TDP1 (0.37) PTPN1ALDH1A1MAPTHPGDLMNA
SCHEMBL6978544 0.74 ALDH1A1 (0.52) ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586442-B2 Benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them CARNIATO DENIS (FR) 2003-07-01 US disclosed
US-20020187976-A1 New benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them AVENTIS PHARMA S.A. 2002-12-12 US disclosed
US-6458801-B1 PHARMACEUTICALLY ACCEPTABLE SALTS AND ITS PRODRUG USEFUL FOR TREATING OSTEOPOROSIS. AVENTIS PHARMA S.A. (FR) 2002-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020187976-A1 New benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them CYP2F1, CYP2C19, CYP2B6 CA12 4808/4885CA14 4561/4885CA2 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.